Skip to main content
Erschienen in: Inflammation Research 11/2014

01.11.2014 | Original Research Paper

Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease

verfasst von: Wenyu Jiang, Jiewen Su, Xiaofei Zhang, Xiuqin Cheng, Jun Zhou, Ruihua Shi, Hongjie Zhang

Erschienen in: Inflammation Research | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

Interleukin-17(IL-17)-producing T helper(Th)17 cells are considered as a new subset of cells critical to the development of inflammatory bowel disease (IBD). We aimed to investigate the distribution of Th17 cells, the expressions of Th17-related cytokines (IL-17, IL-21 and IL-22) and their association with disease activity in IBD patients.

Methods

We collected intestinal tissue biopsies from 40 patients with active ulcerative colitis (UC), 20 patients with active Crohn’s disease (CD) and 20 healthy controls. The distribution of Th17 cells and expressions of Th17-related cytokines in colonic tissues were evaluated by a standard immunohistochemical procedure. Serum IL-17, IL-21 and IL-22 levels were determined by ELISA. Pearson’s and Spearman’s correlation analyses were performed to analyze the correlation between the number of Th17 cells, the expressions of Th17-related cytokines and disease activity index, endoscopic and histological grading, and CRP and PLT levels, respectively.

Results

Compared with healthy controls, the number of Th17 cells and the expressions of IL-17, IL-21 and IL-22 were significantly increased in active IBD patients (P < 0.05). In addition, Pearson’s and Spearman’s correlation analyses showed that the number of Th17 cells and the expressions of Th17-related cytokines were correlated with disease activity index, endoscopic and histological grading, CRP and PLT levels (P < 0.05).

Conclusions

Th17 cells and Th17-related cytokines (IL-17, IL-21 and IL-22) were increased in the intestinal mucosa in active IBD patients and may play an important role in disease activity and mucosal damage.
Literatur
1.
Zurück zum Zitat Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.PubMedCrossRef Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.PubMedCrossRef
2.
Zurück zum Zitat Abraham Clara, Medzhitov Ruslan. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729–37.PubMedCrossRefPubMedCentral Abraham Clara, Medzhitov Ruslan. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729–37.PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Fuss IJ. Is the Th1/Th2 paradigm of immune regulation applicable to IBD? Inflamm Bowel Dis. 2008;14(Suppl. 2):S110–2.PubMedCrossRef Fuss IJ. Is the Th1/Th2 paradigm of immune regulation applicable to IBD? Inflamm Bowel Dis. 2008;14(Suppl. 2):S110–2.PubMedCrossRef
5.
Zurück zum Zitat Fantini MC, Monteleone G, MacDonald TT. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 2008;1(2):110–5.PubMedCrossRef Fantini MC, Monteleone G, MacDonald TT. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 2008;1(2):110–5.PubMedCrossRef
6.
Zurück zum Zitat Andoh A, Zhang Z, Inatomi O, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005;129:969–84.PubMedCrossRef Andoh A, Zhang Z, Inatomi O, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005;129:969–84.PubMedCrossRef
7.
Zurück zum Zitat Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112–24.PubMedCrossRef Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112–24.PubMedCrossRef
8.
Zurück zum Zitat Daperno M, D’ Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.PubMedCrossRef Daperno M, D’ Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.PubMedCrossRef
9.
Zurück zum Zitat Tsai YS, Jou YC, Lee GF, Chen YC, Shiau AL, et al. Aberrant prothymosin-alpha expression in human bladder cancer. Urology. 2009;73:188–92.PubMedCrossRef Tsai YS, Jou YC, Lee GF, Chen YC, Shiau AL, et al. Aberrant prothymosin-alpha expression in human bladder cancer. Urology. 2009;73:188–92.PubMedCrossRef
10.
Zurück zum Zitat Ryu JW, Lee JH, Choi YH, Lee YT, Choi BT. Effects of protein phosphatase inhibitors on the phosphorylation of spinal cord N-methyl-D-aspartate receptors following electroacupuncture stimulation in rats. Brain Res Bull. 2008;75:687–91.PubMedCrossRef Ryu JW, Lee JH, Choi YH, Lee YT, Choi BT. Effects of protein phosphatase inhibitors on the phosphorylation of spinal cord N-methyl-D-aspartate receptors following electroacupuncture stimulation in rats. Brain Res Bull. 2008;75:687–91.PubMedCrossRef
11.
Zurück zum Zitat Raza A, Yousaf W, Giannella R, et al. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8(2):161–8.PubMedCrossRefPubMedCentral Raza A, Yousaf W, Giannella R, et al. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8(2):161–8.PubMedCrossRefPubMedCentral
12.
Zurück zum Zitat Niu Q, Cai B, Huang ZC, et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int. 2011 Aug 2. [Epub ahead of print]. Niu Q, Cai B, Huang ZC, et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int. 2011 Aug 2. [Epub ahead of print].
14.
Zurück zum Zitat Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30(1):80–9.PubMedCrossRef Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30(1):80–9.PubMedCrossRef
15.
Zurück zum Zitat Holtta Veera, Klemetti Paula, Salo Harri M, et al. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;57(3):287–92.PubMedCrossRef Holtta Veera, Klemetti Paula, Salo Harri M, et al. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;57(3):287–92.PubMedCrossRef
16.
Zurück zum Zitat Laan M, Lo¨tvall J, Chung KF, et al. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133:200–6.PubMedCrossRefPubMedCentral Laan M, Lo¨tvall J, Chung KF, et al. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133:200–6.PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Awane M, Andres PG, Li DJ, et al. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNFalpha-, and IL-1beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162:5337–44.PubMed Awane M, Andres PG, Li DJ, et al. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNFalpha-, and IL-1beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162:5337–44.PubMed
18.
19.
20.
Zurück zum Zitat Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86(4):959–69.PubMedCrossRef Bai A, Lu N, Guo Y, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009;86(4):959–69.PubMedCrossRef
21.
Zurück zum Zitat Yamamoto-Furusho JK, Miranda-Pérez E, Fonseca-Camarillo G, et al. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis. Inflamm Bowel Dis. 2010;16(7):1090.PubMedCrossRef Yamamoto-Furusho JK, Miranda-Pérez E, Fonseca-Camarillo G, et al. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis. Inflamm Bowel Dis. 2010;16(7):1090.PubMedCrossRef
22.
Zurück zum Zitat Strengell M, Sareneva T, Foster D, et al. IL-21 up-regulates the expression of gene associated with innate immunity and Th1 response. J Immunol. 2002;169:3600–5.PubMedCrossRef Strengell M, Sareneva T, Foster D, et al. IL-21 up-regulates the expression of gene associated with innate immunity and Th1 response. J Immunol. 2002;169:3600–5.PubMedCrossRef
23.
Zurück zum Zitat Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.PubMedCrossRef Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.PubMedCrossRef
24.
Zurück zum Zitat Qi W, Huang X, Wang J. Correlation between Th17 cells and tumor microenvironment. Cell Immunol. 2013;285(1–2):18–22.PubMedCrossRef Qi W, Huang X, Wang J. Correlation between Th17 cells and tumor microenvironment. Cell Immunol. 2013;285(1–2):18–22.PubMedCrossRef
25.
26.
Zurück zum Zitat Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707–12.PubMedCrossRef Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707–12.PubMedCrossRef
27.
Zurück zum Zitat Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004;89(1):69–71.PubMedPubMedCentral Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004;89(1):69–71.PubMedPubMedCentral
Metadaten
Titel
Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease
verfasst von
Wenyu Jiang
Jiewen Su
Xiaofei Zhang
Xiuqin Cheng
Jun Zhou
Ruihua Shi
Hongjie Zhang
Publikationsdatum
01.11.2014
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 11/2014
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-014-0768-7

Weitere Artikel der Ausgabe 11/2014

Inflammation Research 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.